The previous studies have also described CD13 as the most common aberrant myeloid antigen in B-ALL.5,15,18 CD33 is the second most frequent aberrant myeloid antigen reported. This evidence concerns the gene CD33 and precursor B-cell acute lymphoblastic leukemia.